American Journal of Kidney Diseases
Volume 52, Issue 2 , Pages 294-304 , August 2008

Effect of Hyperosmolality on Vasopressin Secretion in Intradialytic Hypotension: A Mechanistic Study

Received 27 September 2007 ,Accepted 31 March 2008.

References 

  1. Bregman H, Daugirdas JT, Ing TS. Complications during hemodialysis. In:  Daugirdas JT,  Ing TS editor. Handbook of Dialysis. (ed 2). Boston, MA: Little Brown; 1994;p. 13–29
  2. Mujais SK, Ing T, Kjellstrand C. Acute complications of hemodialysis and their prevention and treatment. In:  Jacobs C,  Kjellstrand CM,  Koch KM,  Winchester JF editor. Replacement of Renal Function by Dialysis. (ed 4). The Netherlands, Kluwer: Dordrecht; 1996;p. 688–725
  3. Sulowicz W, Radziszewski A. Pathogenesis and treatment of dialysis hypotension. Kidney Int Suppl. 2006;104:S36–S39
  4. Daugirdas JT. Preventing and managing hypotension. Semin Dial. 1994;7:276–283
  5. Gong R, Lindberg J, Abrams J, Whitaker WR, Wade CE, Gouge S. Comparison of hypertonic saline solutions and dextran in dialysis-induced hypotension. J Am Soc Nephrol. 1993;3:1808–1812
  6. Shimizu K, Nakao A, Nonaka T, Oka H. Identification of vasopressin and determination of its corticomedullary levels in rat kidney tissue. Kidney Int. 1984;26:785–790
  7. Shimizu K, Nakano S, Nakano Y, Ando M, Seki K, Kameda N. Ectopic atrial natriuretic peptide production in small cell lung cancer with the syndrome of inappropriate antidiuretic hormone secretion. Cancer. 1991;68:2284–2288
  8. Rose BD. In: The total body water and the plasma sodium concentration, in Clinical Physiology of Acid-Base and Electrolyte Disorders. (ed 4). New York, NY: McGraw-Hill; 1994;p. 219–234
  9. Sanderson NA, Katz MA. The fate of hypertonic saline administered during hemodialysis. ANNA J. 1994;21:162–170
  10. Kinet JP, Soyeur D, Balland N, Saint-Remy M, Collignon P, Godon J-P. Hemodynamic study of hypotension during hemodialysis. Kidney Int. 1982;21:868–876
  11. Robertson GL, Shelton RL, Athar S. The osmoregulation of vasopressin. Kidney Int. 1976;10:25–37
  12. Nette RW, Van den Dorpel MA, Krepel HP, et al. Hypotension during hemodialysis results from an impairment of arteriolar tone and left ventricular function. Clin Nephrol. 2005;63:276–283
  13. Emili S, Black NA, Paul RV, Rexing CJ, Ullian ME. A protocol-based treatment for intradialytic hypotension in hospitalized hemodialysis patients. Am J Kidney Dis. 1999;33:1107–1114
  14. Schmidt R, Roeher O, Hickstein H, Korth S. Prevention of hemodialysis-induced hypotension by biofeedback control of ultrafiltration and infusion. Nephrol Dial Transplant. 2001;16:595–603
  15. Van der Sande FM, Luik AJ, Kooman JP, Verstappen V, Leunissen KML. Effect of intravenous fluids on blood pressure course during hemodialysis in hypotensive-prone patients. J Am Soc Nephrol. 2000;11:550–555
  16. Henrich WL, Woodard TD, McPhaul JJ. The chronic efficacy and safety of high sodium dialysate: Double-blind, crossover study. Am J Kidney Dis. 1982;2:349–353
  17. Van Kuijk WHM, Wirtz JJJM, Grave W, et al. Vascular reactivity during combined ultrafiltration-hemodialysis: Influence of dialysate sodium. Nephrol Dial Transplant. 1996;11:323–328
  18. Henrich WL, Woodard TD, Blanchley JD, Gomez-Sanchez C, Pettinger W, Cronin RE. Role of osmolality in blood pressure stability after dialysis and ultrafiltration. Kidney Int. 1980;18:480–488
  19. Velasco IT, Pontieri V, Rocha e Silva M, Lopes OU. Hyperosmotic NaCl and severe hemorrhagic shock. Am J Physiol. 1980;239:H664–H673
  20. Horký K, Srámková J, Lachmanová J, Tomásek R, Dvoráková J. Plasma concentration of antidiuretic hormone in patients with chronic renal insufficiency on maintenance dialysis. Horm Metab Res. 1979;11:241–246
  21. Fasanella d'Amore T, Wauters JP, Waeber B, Nussberger J, Brunner HR. Response of plasma vasopressin to changes in extracellular volume and/or plasma osmolality in patients on maintenance hemodialysis. Clin Nephrol. 1985;23:299–302
  22. Jawadi MH, Ho LS, Dipette D, Ross DL. Regulation of plasma arginine vasopressin in patients with chronic renal failure maintained on hemodialysis. Am J Nephrol. 1986;6:175–181
  23. Ardaillou R, Banmansour M, Pruszczynski W. Secretion and metabolism of vasopressin in chronic renal failure. In:  Cowley AW,  Liard J-F,  Ausiello DA editor. Vasopressin: Cellular and Integrative Functions. New York, NY: Raven; 1988;p. 241–247
  24. Lindberg JS, Copley JB, Melton K, Wade CE, Abrams J, Goode D. Lysine vasopressin in the treatment of refractory hemodialysis-induced hypotension. Am J Nephrol. 1990;10:269–275
  25. Van der Zee S, Thompson A, Zimmerman R, et al. Vasopressin administration facilitates fluid removal during hemodialysis. Kidney Int. 2007;71:318–324
  26. Shimizu K, Hoshino M. Application of vasopressin radioimmunoassay to clinical study: Role of vasopressin in hypo- and hypernatremia and some other disorders of water metabolism. Contrib Nephrol. 1978;9:42–60
  27. Shimizu K, Hamazaki T, Ubukata E, Shiratori Y, Harada M. Trials for simplified hypertonic saline test. Folia Endocrinol. 1987;63:164–171
  28. Zerbe RI, Robertson GL. Osmoregulation of thirst and vasopressin secretion in human subjects: Effect of various solutes. Am J Physiol. 1983;244:E607–E614
  29. Wagner HN, Braunwald E. The pressor effect of the antidiuretic principle of the posterior pituitary in orthostatic hypotension. J Clin Invest. 1956;35:1412–1418
  30. Cowley AW, Liard JF. Cardiovascular actions of vasopressin. In:  Gash DM,  Boer GJ editor. Vasopressin, Principles and Properties. New York: Plenum; 1987;p. 389–433
  31. Montani JP, Liard JF, Schoun J, Möhring J. Hemodynamic effects of exogenous and endogenous vasopressin at low plasma concentrations in conscious dogs. Circ Res. 1980;47:346–355
  32. Möhring J, Glänzer K, Maciel JA, et al. Greatly enhanced pressor response to antidiuretic hormone in patients with impaired cardiovascular reflexes due to idiopathic orthostatic hypotension. J Cardiovasc Pharmacol. 1980;2:367–376
  33. Friess U, Rascher W, Ritz E, Gross P. Failure of arginine-vasopressin and other pressor hormones to increase in severe recurrent dialysis hypotension. Nephrol Dial Transplant. 1995;10:1421–1427
  34. Robertson GL. Posterior pituitary. In:  Felig P,  Baxter J,  Frohman LA editor. Endrocrinology and Metabolism. New York, NY: McGraw-Hill; 1986;p. 338–386
  35. Lundvall J, Lindgren P. F-Cell shift and protein loss strongly affect validity of PV reductions indicated by Hb/Hct and plasma proteins. J Appl Physiol. 1998;84:822–829
  36. Dasselaar JJ, Lub-de Hooge MN, Pruim J, et al. Relative blood volume changes underestimate total blood volume changes during hemodialysis. Clin J Am Soc Nephrol. 2007;2:669–674

 Originally published online as doi:10.1053/j.ajkd.2008.03.024 on June 17, 2008.

PII: S0272-6386(08)00740-3

doi: 10.1053/j.ajkd.2008.03.024

American Journal of Kidney Diseases
Volume 52, Issue 2 , Pages 294-304 , August 2008

Article Tools

* Image Usage & Resolution